The Effects of GMA-TULIP, I-gel, and BlockBuster Laryngeal Mask in Surgeries With Lateral Position Under General Anesthesia
Launched by THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY · Jan 14, 2025
Trial Information
Current as of June 07, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying three different types of laryngeal masks used during surgeries where patients are lying on their sides and under general anesthesia. The goal is to compare how well these masks work and how safe they are, particularly focusing on something called oropharyngeal leak pressure, which relates to how well air is kept in the lungs during surgery. This research aims to help doctors choose the best type of laryngeal mask for these specific surgeries.
To participate in this study, you need to be between 18 and 80 years old, have a body mass index (BMI) of less than 28, and be scheduled for a surgery that lasts less than 3 hours while lying on your side. You should also be in good health according to the American Society of Anesthesiologists guidelines (grades I-III). Participants will need to sign a consent form and be able to understand the study process. If you have certain medical conditions or difficulties that might affect your participation, you may not be eligible. Overall, this trial is an important step in improving the safety and effectiveness of anesthesia practices during specific surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients received surgeries in lateral position with an estimated surgery duration of less than 3 hours under general anesthesia.
- • 2. Ages between 18 to 80, and body mass index less than 28 kg/m².
- • 3. American Society of Anesthesiologists (ASA) Grades I-III.
- • 4. Patients are willing to participate and be able to understand and sign an informed consent form.
- Exclusion Criteria:
- • 1. Individuals with an open bite of less than 2cm.
- • 2. Individuals with a history of obvious regurgitation of gastric contents and risk factors for aspiration.
- • 3. Patients with combined pharyngeal and laryngeal lesions.
- • 4. Predicting difficult airway patients.
- • 5. Hearing, intellectual, communication, and cognitive impairments.
- • 6. Any reason that prevents cooperation with the study or that the researcher deems inappropriate for inclusion in this trial.
About The Second Affiliated Hospital Of Chongqing Medical University
The Second Affiliated Hospital of Chongqing Medical University is a leading healthcare institution dedicated to advancing medical research and patient care through innovative clinical trials. As a prominent academic hospital in China, it combines cutting-edge medical technology with a strong emphasis on education and training for healthcare professionals. The hospital is committed to conducting high-quality, ethically sound clinical research that contributes to the development of new therapies and enhances healthcare outcomes. With a multidisciplinary team of experts, the Second Affiliated Hospital fosters collaboration and strives to address critical health challenges through rigorous scientific investigation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chongqing, Chongqing, China
Patients applied
Trial Officials
Bing Chen
Principal Investigator
The Second Affiliated Hospital of Chongqing Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported